Steward Partners Investment Advisory’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Buy |
1,308
+17
| +1% | +$191 | ﹤0.01% | 3035 |
|
|
2025
Q1 | $7.36K | Hold |
1,291
| – | – | ﹤0.01% | 3236 |
|
|
2024
Q4 | $12.7K | Buy |
1,291
+1
| +0.1% | +$10 | ﹤0.01% | 2999 |
|
|
2024
Q3 | $10.5K | Buy |
1,290
+1,110
| +617% | +$9.05K | ﹤0.01% | 2927 |
|
|
2024
Q2 | $2.41K | Sell |
180
-57
| -24% | -$763 | ﹤0.01% | 3245 |
|
|
2024
Q1 | $11K | Sell |
237
-161
| -40% | -$7.48K | ﹤0.01% | 2771 |
|
|
2023
Q4 | $26.9K | Sell |
398
-162
| -29% | -$10.9K | ﹤0.01% | 2260 |
|
|
2023
Q3 | $40.6K | Buy |
560
+75
| +15% | +$5.43K | ﹤0.01% | 1999 |
|
|
2023
Q2 | $36.1K | Buy |
485
+25
| +5% | +$1.86K | ﹤0.01% | 2019 |
|
|
2023
Q1 | $24.5K | Buy |
460
+110
| +31% | +$5.86K | ﹤0.01% | 2163 |
|
|
2022
Q4 | $23.7K | Buy |
350
+87
| +33% | +$5.89K | ﹤0.01% | 2157 |
|
|
2022
Q3 | $33K | Buy |
263
+139
| +112% | +$17.4K | ﹤0.01% | 1975 |
|
|
2022
Q2 | $12K | Buy |
124
+16
| +15% | +$1.55K | ﹤0.01% | 2440 |
|
|
2022
Q1 | $17K | Buy |
108
+35
| +48% | +$5.51K | ﹤0.01% | 2440 |
|
|
2021
Q4 | $24K | Buy |
73
+8
| +12% | +$2.63K | ﹤0.01% | 2241 |
|
|
2021
Q3 | $30K | Buy |
+65
| New | +$30K | ﹤0.01% | 2127 |
|